Lumibird: surrounded after its half-year results
Sales for the laser technology specialist came to €97.2 million, up 16% (+17% on a like-for-like basis), including increases of 19% for the Photonics division and 13% for the Medical division.
Lumibird is maintaining its objectives for the year, i.e. organic growth in excess of 8% per annum on the scope of consolidation to the end of 2022, and an EBITDA margin (excluding Convergent Photonics) in excess of 20%, taking into account strong seasonality.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction